PFDSelect Medical Receivables 1020, LLC has filed an amendment to its previous offering, adjusting the total offering amount to $21 million. This amendment is significant as it reflects the company’s ongoing efforts to secure funding in the competitive financial services sector.

The company, incorporated in Nevada, is involved in the medical receivables industry. It is part of the broader category of Other Banking and Financial Services. The recent filing indicates that PFDSelect has successfully raised over $18 million to date, leaving approximately $2.5 million remaining in the offering.

According to the filing, the amendment was made effective as of October 29, 2026. The filing notes that the total amount sold is $18,422,717, with a remaining balance of $2,577,283 still available for investment.

The filing specifies that there are 95 investors already involved, and it does not include non-accredited investors. The minimum investment accepted is set at $10,000, which may appeal to a range of potential investors.

While the filing provides a clear picture of the current status of the offering, it does not outline what steps will follow this amendment. As such, stakeholders and potential investors will be watching closely for any further updates from the company.

Company Overview

PFDSelect Medical Receivables 1020, LLC is structured as a Limited Liability Company and was incorporated in Nevada in 2026. The company operates under the management of PFD Capital Partners, Inc., which is also a Nevada corporation. The current fiscal year for the company ends on December 31.

Management Team

The filing lists several key individuals associated with the company, including Gary L. Ermoian, who serves as an Executive Officer and Director of PFD Capital Partners, Inc. Additionally, Robert E. Pryke and Eric E. Hansen are also Executive Officers of PFD Capital Partners, Inc. Their involvement highlights the leadership team's experience within the financial services sector.

Offering Details

The offering is classified under the SEC exemption 06c, allowing the company to raise funds without registering the securities with the SEC. The first sale of securities occurred on July 7, 2026, and the offering is expected to last more than one year, indicating a long-term strategy for capital acquisition.

While the filing provides a detailed overview of the offering and the management team, it does not include specific information on how the raised funds will be utilized or any projected financial performance metrics for the company.